Monthly archive | PharmaTutor

Read more about EMA launches a social media campaign to highlight how the European medicines regulatory network keeps medicines available in Europe safe and effective

EMA launches a social media campaign to highlight how the European medicines regulatory network keeps medicines available in Europe safe and effective.
As of today, EMA will start sharing a series of info-cards on its Twitter and LinkedIn accounts.

Read more about WHO calls for more investment in primary health care

Primary health care is key to solving the health challenges facing countries in Asia and the Pacific, according to the World Health Organization (WHO).

WHO says that investment in primary health care is essential to provide access for the most vulnerable, build more equitable societies and help economies grow.

Read more about FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

U.S. Food and Drug Administration approved Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) capsules for the treatment of the heart disease (cardiomyopathy) caused by transthyretin mediated amyloidosis (ATTR-CM) in adults. These are the first FDA-approved treatments for ATTR-CM. Vyndaqel and Vyndamax have the same active moiety, tafamidis, but they are not substitutable on a milligram to milligram basis and their recommended doses differ.

Read more about FDA approves first treatment for children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder

The U.S. Food and Drug Administration approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age. This is the first FDA approval of a treatment specifically for pediatric patients with LEMS. The only other treatment approved for LEMS is only approved for use in adults.

Read more about Anti HIV Medicine can reduce risk of HIV Acquisition

Pre-exposure prophylaxis (PrEP), a combination drug used to prevent HIV infection, has already gained significant traction in the U.S. and Europe. The once-a-day pill, when taken consistently, can reduce the risk of HIV acquisition by over 85 percent. A new study published in Clinical Infectious Diseases by an international research team suggests that making PrEP available to men who have sex with men (MSM) and people who inject drugs (PWID) in India may be a cost-effective way of curbing the epidemic there.

10 May 2019

Walk in interview for Pharmacist, Lab Technician, Project Coordinator at HLL Lifecare Limited - Public Sector Enterprise

HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services. With state-of-the-art manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare infrastructure development and facility management.

10 May 2019

Career for M.Pharm, M.Sc as Senior Research Fellow at Central Council for Research in Ayurvedic Sciences

The Central Council for Research in Ayurvedic Sciences (CCRAS) is an autonomous body of the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy), Government of India. It is an apex body in India for the formulation, coordination, development and promotion of research on scientific lines in Ayurveda and Sowa-Rigpa system of medicine.

Post : Senior Research Fellow (Chemistry) - 01

10 May 2019

Recruitment for General Manager, Dy Manager at IDPL | Govt. of India Undertaking

IDPL is the largest Central Pharma Public Sector Undertaking in India with plants at Rishikesh, Gurgaon & Hyderabad and two Subsidiary Units at Chennai and Muzaffarpur. IDPL played a major role in the strategic National Health Programmes like Family Welfare Programme & Population Control (Mala-D & Mala-N) anti-malarials (Chloroquine) and prevention of dehydration (ORS) by providing quality medicines. During the country’s calamity of outbreak of Plague in 1994, IDPL was the only company which played the sheet anchor role in supplying Tetracycline for the entire Nation. Similarly, company had made uninterrupted supply of Chloroquine to combat Malaria epidemic in different parts of the country. In 2005 to combat national emergency (leptospirosis) arising due to flood in Maharastra, IDPL had supplied required Doxycycline Caps. within no time.

10 May 2019

Job for Dean, Professor, Associate Professor, Assistant Professor at Guru Nanak Institutions

Established under the aegis of the Guru Nanak Institutions in 2006, the College has been a nurturing ground for pharmaceutical professionals. School Of Pharmacy GNITC is approved by the AICTE and Pharmacy Council of India, New Delhi and is affiliated to Jawaharlal Nehru Technological University, Hyderabad with permanent affiliation. It is also approved by the UGC as an autonomous Institution .The Institute is further recognized u/s 2f & 12 B of UGC Act. The Institute offers a four year B. Pharm programme, six years Pharm D, and three year Pharm.D (PB) apart from two year M.Pharm programme.

Post : Dean/Professor/Associate Professor/Assistant Professors

10 May 2019

Job for Sales Executive at Altmann Pharmaceuticals Pvt. Ltd

Altmann began operations as a healthcare marketing company and offering high quality products and services. We at Altmann are committed to our customers and employees and, more importantly, to the people who rely on our medicines. Our teams work towards reinventing available healthcare options by combining knowledge of advancements in diagnosis and treatment with innovation in patient care practices to bring superior products to the market.

Post : Sales Executive

Search

May 2019

RECOMMENDED POSTS

Subscribe with us

Jobs by Category